Meril Life Sciences Pvt Ltd:製品パイプライン分析

◆英語タイトル:Meril Life Sciences Pvt Ltd - Product Pipeline Analysis, 2017 Update
◆商品コード:DATA8013774
◆発行会社(調査会社):GlobalData
◆発行日:2017年10月27日
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Meril Life Sciences Pvt Ltd (Meril) is a medical device company that develops and designs clinically relevant devices. The company’s product categories include cardiovascular devices, vascular interventional devices, orthopedic devices, in-vitro diagnostics devices and endo-surgery devices. It offers coronary drug eluting stents, coronary bare metal stents, PTCA balloon dilatation catheter, bioresorbable scaffold, trans-catheters, knee systems and acetabular cup systems, IVD analyzers and reagents, surgical sutures, tissue sealants, absorbable hemostats, mesh, intra uterine devices, access devices, lab consumables, energy devices and staplers, accessories, and others. The company sells its products through direct sales, distributors and representatives offices located in India, Germany, Turkey, the US, China and Brazil. Meril is headquartered in Vapi, Gujarat, India.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Meril Life Sciences Pvt Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Meril Life Sciences Pvt Ltd Company Overview 5
Meril Life Sciences Pvt Ltd Company Snapshot 5
Meril Life Sciences Pvt Ltd Pipeline Products and Ongoing Clinical Trials Overview 6
Meril Life Sciences Pvt Ltd – Pipeline Analysis Overview 8
Meril Life Sciences Pvt Ltd – Key Facts 8
Meril Life Sciences Pvt Ltd – Major Products and Services 9
Meril Life Sciences Pvt Ltd Pipeline Products by Development Stage 11
Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status 13
Meril Life Sciences Pvt Ltd Pipeline Products Overview 15
BioMime 15
BioMime Product Overview 15
BioMime Clinical Trial 16
BIOMIME AURA 18
BIOMIME AURA Product Overview 18
BIOMIME AURA Clinical Trial 19
Credence – Peripheral BRS 20
Credence – Peripheral BRS Product Overview 20
Credence – Peripheral BRS Clinical Trial 21
Crypton Stainless Steel Coronary Stent System 22
Crypton Stainless Steel Coronary Stent System Product Overview 22
MeRes100 23
MeRes100 Product Overview 23
MeRes100 Clinical Trial 24
Myval Transcatheter Aortic Valve Replacement System 25
Myval Transcatheter Aortic Valve Replacement System Product Overview 25
NEXGEN Cobalt Chromium Coronary Stent System 26
NEXGEN Cobalt Chromium Coronary Stent System Product Overview 26
Meril Life Sciences Pvt Ltd – Key Competitors 27
Meril Life Sciences Pvt Ltd – Key Employees 28
Meril Life Sciences Pvt Ltd – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Appendix 30
Methodology 30
About GlobalData 32
Contact Us 32
Disclaimer 33

List of Tables
Meril Life Sciences Pvt Ltd Pipeline Products and Ongoing Clinical Trials Overview 6
Meril Life Sciences Pvt Ltd Pipeline Products by Equipment Type 6
Meril Life Sciences Pvt Ltd Pipeline Products by Indication 7
Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status 7
Meril Life Sciences Pvt Ltd, Key Facts 8
Meril Life Sciences Pvt Ltd, Major Products and Services 9
Meril Life Sciences Pvt Ltd Number of Pipeline Products by Development Stage 11
Meril Life Sciences Pvt Ltd Pipeline Products Summary by Development Stage 12
Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status 13
Meril Life Sciences Pvt Ltd Ongoing Clinical Trials Summary 14
BioMime - Product Status 15
BioMime - Product Description 15
BioMime - A Prospective, Active Control Open Label, Multicenter Randomized Clinical Trial for Comparison Between BioMime Sirolimus Eluting Stent of and Xience Everolimus Eluting Stent to Evaluate Efficacy and Safety in Coronary Artery Disease 16
BioMime - A Prospective, Single-arm, Multi-center, Observational, Real World Registry to Evaluate Safety and Performance of the BioMime Morph Sirolimus Eluting Coronary Stent System for Very Long Coronary Lesions 16
BioMime - Biomime Biosorbable Polymer Sirolimus-eluting Stent in All-comers Patients Treated with Percutaneous Coronary Interventions: The BELLINI Registry 16
BioMime - Randomized Study to Evaluate Segmental Late Loss Comparing Two PCI Strategies Using a Long Stent vs 2 Shorter Stents to Treat Long or Tandem Coronary Stenosis 16
BioMime - Real World Drug-eluting Stent Prospective, Open, Multi-site, Registry in Korea: Biomimetm Stent, Ultimaster Stent versus Xience Stent by Smart Angioplasty Research Team (SMARTDESK-MX) 17
BIOMIME AURA - Product Status 18
BIOMIME AURA - Product Description 18
BIOMIME AURA - Randomized Study to Evaluate Segmental Late Loss Comparing Two PCI Strategies Using a Long Stent vs 2 Shorter Stents to Treat Long or Tandem Coronary Stenosis 19
Credence - Peripheral BRS - Product Status 20
Credence - Peripheral BRS - Product Description 20
Credence - Peripheral BRS - A Prospective, Multicentered and Open Label Clinical Study to Evaluate Safety and Performance of Credence Btk Sirolimus Eluting Bioresorbable Peripheral Scaffold System in Subjects with Critical Limb Ischemia Following Percutaneous Transluminal Angioplasty of Below the Knee Arteries 21
Credence - Peripheral BRS - Credence BRS 1: A Prospective, Open Label and Multicentric Clinical Study to Evaluate Safety and Performance of Credence BRS Sirolimus Eluting Bioresorbable Peripheral Scaffold System in Subjects with De Novo Native Peripheral Artery Lesions 21
Crypton Stainless Steel Coronary Stent System - Product Status 22
Crypton Stainless Steel Coronary Stent System - Product Description 22
MeRes100 - Product Status 23
MeRes100 - Product Description 23
MeRes100 - A Prospective, Multinational, Multicenter, Single Arm, Open Label, Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System in the Treatment of De-novo Native Coronary Artery Lesions (MeRes-1 Extend) 24
Myval Transcatheter Aortic Valve Replacement System - Product Status 25
Myval Transcatheter Aortic Valve Replacement System - Product Description 25
NEXGEN Cobalt Chromium Coronary Stent System - Product Status 26
NEXGEN Cobalt Chromium Coronary Stent System - Product Description 26
Meril Life Sciences Pvt Ltd, Key Employees 28
Meril Life Sciences Pvt Ltd, Other Locations 29
Meril Life Sciences Pvt Ltd, Subsidiaries 29
Glossary 31

★海外企業調査レポート[Meril Life Sciences Pvt Ltd:製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SciBase AB (SCIB):企業の財務・戦略的SWOT分析
    Summary SciBase AB (SciBase) is a medical technology company that offers non-invasive detection and monitoring of skin tissue alterations. The company develops point of care device for the accurate detection of malignant melanoma. It offers electrical impedance spectroscopy which uses the varying el …
  • Labeyrie Fine Foods:企業の戦略・SWOT・財務情報
    Labeyrie Fine Foods - Strategy, SWOT and Corporate Finance Report Summary Labeyrie Fine Foods - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • United India Insurance Co Ltd:企業の戦略・SWOT・財務分析
    United India Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary United India Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Chr. Hansen Holding A/S:企業の戦略・SWOT・財務分析
    Chr. Hansen Holding A/S - Strategy, SWOT and Corporate Finance Report Summary Chr. Hansen Holding A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • GP Pharm SA:製薬・医療:M&Aディール及び事業提携情報
    Summary GP Pharm SA (GP Pharm) is a biopharmaceutical company that develops and markets injectables in the areas of oncology and urology. The company provides product portfolio such as injectable dosage forms for the treatment of advanced prostate cancer; nocturnal enuresis and central diabetes insi …
  • Dana Inc:企業の戦略・SWOT・財務分析
    Dana Inc - Strategy, SWOT and Corporate Finance Report Summary Dana Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Trevena Inc (TRVN):企業の財務・戦略的SWOT分析
    Summary Trevena Inc (Trevena) is a biotechnology company that discovers and develops G-protein coupled receptor targeted medicines. The company provides products such as RV027, TRV130, TRV734 and TRV250. Its TRV027 is an intravenous drug used for the treatment of acute heart failure in combination w …
  • CardioNet Inc:医療機器:M&Aディール及び事業提携情報
    Summary CardioNet Inc (CardioNet), a subsidiary of BioTelemetry Inc is a medical device company that develops and markets medical telemetry devices for the healthcare sectors. The company provides proprietary technology and system, mobile cardiac outpatient telemetry that is used in the ECG monitori …
  • China Telecom Corporation Limited:企業の戦略・SWOT・財務情報
    China Telecom Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary China Telecom Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Dubai Electricity and Water Authority-エネルギー分野:企業M&A・提携分析
    Summary Dubai Electricity and Water Authority (DEWA) generates, transmits and distributes electricity; and conducts desalination of water. DEWA’s power plants included Jebel Ali Power Station D, E, G, K, L Phase I, L Phase II, and M; Aweer Power Station H Phase I, Phase II, and Phase III. The desali …
  • Nuclear Power Corporation of India Ltd:企業の戦略的SWOT分析
    Nuclear Power Corporation of India Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Apogenix AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Apogenix AG (Apogenix) is a developer of immuno-oncology medicines for the treatment of oncological and malignant hematological diseases. The company’s pipeline drug candidates under clinical development include APG101, a CD95 ligand inhibitor for the treatment of glioblastoma and myelodyspl …
  • Shutterfly Inc:企業の戦略的SWOT分析
    Shutterfly Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Anheuser-Busch InBev SA/NV:企業の戦略・SWOT・財務分析
    Anheuser-Busch InBev SA/NV - Strategy, SWOT and Corporate Finance Report Summary Anheuser-Busch InBev SA/NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Alsea SAB de CV:企業の戦略・SWOT・財務情報
    Alsea SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Alsea SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Lorain-Medina Rural Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Lorain-Medina Rural Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • curasan AG (CUR):企業の財務・戦略的SWOT分析
    curasan AG (CUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • BOE Technology Group Co Ltd:企業の戦略・SWOT・財務情報
    BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Space Hellas S.A. (SPACE):企業の財務・戦略的SWOT分析
    Space Hellas S.A. (SPACE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • ERI Bancaire SA:企業の戦略的SWOT分析
    ERI Bancaire SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆